WHO ICTRP trial

Comparative analysis of the the benefits of intervention with normothermic…

CTRI/2025/07/090676 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2025/07/090676
Public title Comparative analysis of the the benefits of intervention with normothermic intraperitoneal chemotherapy in primary cytoreductive surgery for participants with advanced epithelial ovarian cancer- A Pilot study
Scientific title Comparative analysis of normothermic intraperitoneal chemotherapy in primary cytoreductive surgery for advanced epithelial ovarian cancer- A Pilot study - NIL
Primary sponsor All India Institute of Medical Sciences Rishikesh
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries India
Conditions Health Condition 1: C569- Malignant neoplasm of unspecifiedovary Health Condition 2: O- Medical and Surgical
Interventions Intervention1: normothermic intraperitoneal chemotherapy administration during primary cytoreduction surgery: Eligible patients of advanced epithelial ovarian malignancy who have achieved optimum cytoreduction during primary cytoreduction…
Registration date Oct 7, 2025
Target size 25
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations